ANMAT levantó la inhibición de las actividades productivas de Lassen Pharma S.A
Publisher
Argentina
This page provides publisher metadata, and related coverage to support discovery before sending readers to the publisher's original article.
Read originalAt a glance
- Publisher
- ANMAT Noticias
- Region
- Argentina
- Scope
- Regulatory
- Published
- September 30, 2026
Publisher context, original article off-platform
This page presents the title, publisher metadata, and related coverage. The publisher did not provide a public summary in this feed. Full-text reading stays on the publisher's original site.
Source route
Continue on argentina.gob.ar
Leave the platform to read the original full article on the publisher site.
Source: ANMAT Noticias
Scope: Regulatory
Evidence: Tier 1 · Regulatory source
Related coverage
More related coverage
Επίσκεψη του Προέδρου του ΕΟΦ στον Οργανισμό Φαρμάκων της Πολωνίας
Hepatitis A/B vaccine: patient group direction template
Patient group direction (PGD) template to support the provision of hepatitis A and B (HepA/B) vaccin...
Hepatitis A vaccine: patient group direction (PGD) template
PGD template to support the provision of hepatitis A vaccine to individuals pre- and post-exposure t...
Generalised UK habit data for use in radiological impact assessments
Typical and high-rate values for habit data for use in estimating the radiation dose to different ag...